<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Theis JL</submitter><funding>Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome at Mayo Clinic Foundation</funding><funding>NIA NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>e59554</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7581429</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9</volume><pubmed_abstract>Congenital heart diseases (CHDs), including hypoplastic left heart syndrome (HLHS), are genetically complex and poorly understood. Here, a multidisciplinary platform was established to functionally evaluate novel CHD gene candidates, based on whole-genome and iPSC RNA sequencing of a HLHS family-trio. Filtering for rare variants and altered expression in proband iPSCs prioritized 10 candidates. siRNA/RNAi-mediated knockdown in healthy human iPSC-derived cardiomyocytes (hiPSC-CM) and in developing &lt;i>Drosophila&lt;/i> and zebrafish hearts revealed that LDL receptor-related protein &lt;i>LRP2&lt;/i> is required for cardiomyocyte proliferation and differentiation. Consistent with hypoplastic heart defects, compared to patents the proband's iPSC-CMs exhibited reduced proliferation. Interestingly, rare,</pubmed_abstract><journal>eLife</journal><pubmed_title>Patient-specific genomics and cross-species functional analysis implicate LRP2 in hypoplastic left heart syndrome.</pubmed_title><pmcid>PMC7581429</pmcid><funding_grant_id>HL054732</funding_grant_id><funding_grant_id>SAN-233970</funding_grant_id><funding_grant_id>R21 AG061598</funding_grant_id><funding_grant_id>R01 HL132241</funding_grant_id><funding_grant_id>R01 HL054732</funding_grant_id><funding_grant_id>R01 HL153645</funding_grant_id><funding_grant_id>R01 HL148827</funding_grant_id><pubmed_authors>Bodmer R</pubmed_authors><pubmed_authors>Nelson TJ</pubmed_authors><pubmed_authors>Missinato MA</pubmed_authors><pubmed_authors>Walls SM</pubmed_authors><pubmed_authors>Colas AR</pubmed_authors><pubmed_authors>Theis JL</pubmed_authors><pubmed_authors>Martinez-Fernandez A</pubmed_authors><pubmed_authors>Zeng XI</pubmed_authors><pubmed_authors>Ocorr K</pubmed_authors><pubmed_authors>Fogarty ZC</pubmed_authors><pubmed_authors>Kezos JN</pubmed_authors><pubmed_authors>Olson TM</pubmed_authors><pubmed_authors>Vogler G</pubmed_authors><pubmed_authors>Birker K</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Nielsen T</pubmed_authors><pubmed_authors>Evans JM</pubmed_authors><pubmed_authors>Grossfeld P</pubmed_authors><pubmed_authors>Terzic A</pubmed_authors><pubmed_authors>O'Byrne MM</pubmed_authors><pubmed_authors>Kervadec A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Patient-specific genomics and cross-species functional analysis implicate LRP2 in hypoplastic left heart syndrome.</name><description>Congenital heart diseases (CHDs), including hypoplastic left heart syndrome (HLHS), are genetically complex and poorly understood. Here, a multidisciplinary platform was established to functionally evaluate novel CHD gene candidates, based on whole-genome and iPSC RNA sequencing of a HLHS family-trio. Filtering for rare variants and altered expression in proband iPSCs prioritized 10 candidates. siRNA/RNAi-mediated knockdown in healthy human iPSC-derived cardiomyocytes (hiPSC-CM) and in developing &lt;i>Drosophila&lt;/i> and zebrafish hearts revealed that LDL receptor-related protein &lt;i>LRP2&lt;/i> is required for cardiomyocyte proliferation and differentiation. Consistent with hypoplastic heart defects, compared to patents the proband's iPSC-CMs exhibited reduced proliferation. Interestingly, rare,</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2026-05-03T00:21:11.669Z</modification><creation>2020-10-29T15:57:25Z</creation></dates><accession>S-EPMC7581429</accession><cross_references><pubmed>33006316</pubmed><doi>10.7554/eLife.59554</doi></cross_references></HashMap>